Trump’s Pharma Tariff: A Double-Edged Sword for Indian Drugmakers and US Consumers
US President Donald Trump’s announcement of a 100% tariff on branded and patented pharmaceutical drugs may have far-reaching consequences for Indian drugmakers and US consumers alike.